Requip is the first drug approved for restless legs syndrome
June 2005
Requip is the first drug approved for restless legs syndrome.
About 10% of Americans get these overpowering urges to move their legs...especially when at rest.
Ropinirole (Requip) is a dopamine agonist...like pramipexole (Mirapex) and pergolide (Permax). They're thought to help by boosting dopamine, a neurotransmitter that controls movement.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote